Use of CSF biomarkers in Alzheimer's disease clinical trials.
Blennow
K
K
Clinical Neurochemistry Lab, The Sahlgrenska Academy at Goteborg University, Sahlgrenska University Hospital, SE-431 80 Mölndal, Sweden. KAJ.BLENNOW@NEURO.GU.SE
Zetterberg
H
H
D000544:Alzheimer Disease / Q000134:cerebrospinal fluid*; D015415:Biomarkers / Q000134:cerebrospinal fluid*; D002986:Clinical Trials as Topic; D006801:Humans
D015415:Biomarkers